Markets
Palantir could provide the the model for the AI software trade
(CSA Archive/Getty Images)

Behold the new AI trade: We call it software

As the AI trade broadens out from data-center-driven hyperscalers and power providers, software shares could be poised to catch a lift, Goldman Sachs analysts say.

Matt Phillips

Software has been something of a laggard in the world of tech over the last year, as investor dollars flocked to the sexiest — and most high-performing — hyperscalers, power providers, and electrical equipment makers poised to profit from the AI data center boom. (You know the names: Nvidia, Meta, GE Vernova, etc.)

But a change may be afoot.

After outperforming for much of the last year, the AI data center trade has run into a bit of headwind over the last couple weeks.

At the same time, several — let’s just say it — incredibly boring business-to-business data management software companies like Datadog, Snowflake, Autodesk, and Pure Storage have had a bit of a run, partly driven by surprisingly strong earnings results.

Such outsized pops in response to earnings are the market’s way of giving investors a bracing slap in the face. Over the last month, AI software has actually been outperforming the AI giants.

They’re potentially worth paying attention to, as they suggest a sudden shift in the slightly sour sentiment that has surrounded software since the advent of the AI era.

Until recently, the rap on software was, essentially, that AI stood to potentially disrupt and undercut the immensely profitable “software as a service” (SaaS) industry.

The logic was that AI-native software shops would emerge with the ability to produce software super cheaply. They would then sell those products at much lower prices, taking market share from companies that currently dominate the software business.

But as Goldman Sachs analysts wrote in a recent note titled, “Updated thoughts on the ‘Death of Software,’” the reality seems to be that large software companies are rapidly embracing AI technology themselves, adopting a hybrid strategy.

The analysts cited a number of such SaaS companies that are increasingly embedding AI into their products:

  • Salesforce (Agentforce model)

  • Twilio (ConversationRelay large language model)

  • ServiceNow (Now LLMs for core workflows)

  • OneStream (has access to Microsoft’s LLMs)

They wrote:

A hybrid AI model strategy reduces disintermediation risk and increases platform defensibility — keeping incumbents at the core of AI value even as frontier models evolve. Customers gain Gen AI capabilities via trusted, embedded platforms with secure data environments, workflow alignment and cost-efficient execution — without moving to less tested AI-native challengers.”

The last point is important. Buyers of business software are incredibly sensitive to a range of risks, from reputation threats to data security, and are subject to regulatory and legal scrutiny, which provides something of a defensive moat for current software companies.

Anyway, this is largely just one bank’s view. And even its analysts warn that “given the pace at which the ecosystem is moving, many of our predictions may ultimately be wrong.”

Still, given recent fireworks following software companies’ earnings reports, it could be a profitable area for investors to watch.

More Markets

See all Markets
markets

Intel sinks on news it will hang on to networking unit

Intel dropped in early trading Thursday after it disclosed plans to retain ownership of its networking unit following a strategic review of operations.

The unit, known as NEX, makes products like infrastructure processors, which do needed “housekeeping” tasks like running security checks, thereby freeing core Intel CPUs to do the higher-value operations. It also produces switches and controllers that manage and direct the flow of data to CPUs.

markets

Quantum computing stocks soar on return of bullish options bets

The calendar says December, but the price action is starting to look a lot more like September to me:

Quantum computing companies IonQ, Rigetti Computing, and D-Wave Quantum are all up at least 7% as of 11:04 a.m. ET, buoyed by a wave of bullish options activity.

  • Nearly 50,000 calls in IonQ have already changed hands, well above the 20-day average for a full session, with activity concentrated in strikes from $50 to $55 in contracts that expire between Friday and mid-January. Its put/call ratio is near 0.2, versus an average of over 1 for the past 20 sessions.

  • More than 65,000 calls have traded in Rigetti, a hair shy of its full 20-day average. Like IonQ, options activity has a bullish tilt, with a put/call ratio of about 0.7 versus a 20-day average of roughly 1.2.

  • D-Wave, which received positive commentary from Evercore ISI on Wednesday, isn’t seeing call activity as elevated as its peers, but the options action is also very skewed toward the bull side, with a put/call ratio of less than 0.3 versus a 20-session average of 0.7.

Pure-play quantum computing stocks nearly doubled from late August to late September amid heavy options market activity thanks to reports on government support for the sector, M&A activity, tech breakthroughs, and a flurry of price target hikes by Wall Street.

markets

Hims announces acquisition of Canadian telehealth firm Livewell

Hims & Hers rose in early trading after it announced its acquisition of Livewell, a Canadian telehealth company, marking its official entrance to that market.

The company announced in July that it would expand into Canada by 2026, taking advantage of the patent expiry for semaglutide, the active ingredient in Novo Nordisk’s blockbuster GLP-1s, Ozempic and Wegovy. Hims said Thursday that it would do that through an all-cash acquisition of Livewell.

Novo’s patent on semaglutide is set to expire in Canada in January. It would be the first time generics for the blockbuster GLP-1 drugs are available anywhere, and generic drugmaker Sandoz International has already announced plans to make copies of the drug. In the US, Hims sells copycat versions of Novo’s drugs, which has led to conflict between the companies.

On Wednesday, Hims announced that it would purchase YourBio, a device that uses “bladeless microneedles thinner than an eyelash” to collect blood samples, in another all-cash deal. According to its latest quarterly filing, the company had $345.8 million in cash and cash equivalents.

markets

Symbiotic tanks as company and SoftBank, its largest shareholder, announce offering of 10 million shares

Symbiotic was among the robotics companies that popped on Wednesday, gaining nearly 10% on the news that the Trump administration was on the precipice of a major push to support the industry.

So naturally, management thinks its a good time to sell shares — and its largest shareholder, SoftBank, agrees.

After the close on Wednesday, management announced an offering of 10 million shares, with 6.5 million of that as a primary offering from the company to raise money for general corporate purposes, and 3.5 million from a secondary sale by SoftBank, which owns over one-third of its shares.

The stock cratered on the announcement, giving back all of its one-day gains and then some.

Symbiotic went public in 2022 through a SPAC merger with a SoftBank-backed affiliate.

In October, SoftBank sold its entire $5.8 billion stake in Nvidia to meet an upcoming payment to OpenAI to finance its equity position in the company. Since SoftBank is slated to pay the ChatGPT maker more than $20 billion this month, it would appear that this is another step toward raising the needed cash for that position.

We’ll see if this divestment makes SoftBank founder Masayoshi Son cry.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.